Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sleep deprivation accelerates the response to nortriptyline

R C Shelton1, P T Loosen

  • 1Department of Psychiatry, Vanderbilt University School of Medicine, Nashville, TN.

Progress in Neuro-Psychopharmacology & Biological Psychiatry
|January 1, 1993
PubMed
Summary

Combining sleep deprivation with nortriptyline effectively treated major depressive disorder (MDD). Over half of patients responded rapidly, showing this combined approach is a safe and effective treatment option.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular analyses of circadian gene variants reveal sex-dependent links between depression and clocks.

Translational psychiatry·2016
Same author

Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder.

Acta psychiatrica Scandinavica·2015
Same author

Fibroblasts from patients with major depressive disorder show distinct transcriptional response to metabolic stressors.

Translational psychiatry·2015
Same author

Assessment of a multi-assay, serum-based biological diagnostic test for major depressive disorder: a pilot and replication study.

Molecular psychiatry·2011
Same author

Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression.

Molecular psychiatry·2010
Same author

Can pharmacotherapists be too supportive? A process study of active medication and placebo in the treatment of depression.

Psychological medicine·2009

Area of Science:

  • Psychiatry
  • Neuroscience
  • Pharmacology

Background:

  • Major depressive disorder (MDD) is a prevalent and debilitating mental health condition.
  • Current treatments for MDD, including antidepressants, can have delayed onset of action.
  • Sleep deprivation (SD) has shown transient antidepressant effects.

Purpose of the Study:

  • To investigate the efficacy and safety of combining total sleep deprivation (SD) with nortriptyline for treating major depressive disorder (MDD).
  • To identify predictors of response to this combined treatment regimen.

Main Methods:

  • Twenty patients diagnosed with MDD underwent a 36-hour total sleep deprivation (SD) procedure.
  • Nortriptyline was initiated on the evening following SD, with patients monitored for two weeks.

Related Experiment Videos

  • Response to treatment was assessed, and factors associated with response were analyzed.

    • Main Results:

    • Eleven out of twenty (55%) patients demonstrated a positive response to the combined treatment.
    • Responders experienced rapid and sustained mood improvement following SD.
    • Non-responders showed a delayed therapeutic effect consistent with standard nortriptyline treatment.
    • High baseline depression severity and absence of depersonalization predicted response to SD.
    • Female gender and middle insomnia were associated with response to the combined regimen.

    Conclusions:

    • The combination of sleep deprivation (SD) and nortriptyline is an effective and safe therapeutic strategy for major depressive disorder (MDD).
    • This combined approach offers a potential for rapid symptom remission in a subset of MDD patients.
    • Predictors of response can help personalize treatment selection for MDD.